Clinical Trial Results: SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing SBRT with immunotherapy for early-stage non-small cell lung cancer, focusing on tolerability and lung effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Non-small Cell Lung Cancer Stage II, Non-small Cell Lung Cancer Stage I | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-07-17